Upload

Loading icon Loading...

This video is unavailable.

New Meds in Development: TK2

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to like PhRMAPress's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to dislike PhRMAPress's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to add PhRMAPress's video to your playlist.

Published on Nov 6, 2013

TK-2 related mitochondrial DNA depletion syndrome, myopathic form, is an inherited condition that causes progressive muscle weakness. It typically begins in early childhood.

America's biopharmaceutical companies are developing 452 new medicines to treat rare diseases.

Loading icon Loading...

Loading icon Loading...

Loading icon Loading...

Loading icon Loading...

Ratings have been disabled for this video.
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.

Loading icon Loading...

Loading...
Working...
Sign in to add this to Watch Later

Add to